Dialog Box

Loading...

Table of Targeted Therapies

Type of lymphoma Newer drugs
Chronic lymphocytic leukaemia (CLL)/small lymphocytic leukaemia (SLL) Ibrutinib
Idelalisib
Obinutuzumab
Ofatumumab
Lenalidomide
ABT 199
Diffuse large B cell lymphoma (DLBCL) Bortezomib
Ibrutinib
Lenalidomide
ObinutuzumabABT199
Follicular lymphoma Idelalisib
Ibrutinib
Lenalidomide
Obinutuzumab
Ofatumumab
ABT199
Revlimid
Hodgkin lymphoma Brentuximab vedotin
Mantle cell lymphoma Bortezomib
Ibrutinib
Temsirolimus
Lenalidomide
Marginal zone lymphoma Ibrutinib
Idelalisib
Lenalidomide
Richter’s syndrome (transformation of B-cell CLL) Ofatumunab
Nivolumab
Ibrutinub
Skin lymphoma Brentuximab vedotin
Romidepsin
Vorinostat
Systemic anaplastic large cell lymphoma Brentuximab vedotin
T-cell lymphoma Belinostat
Brentuximab vedotin
Lenalidomide
Romidepsin
Waldenström’s macroglobulinaemia Ibrutinib
Bortezomib
Idelalisib